Immortalized Mouse Schwann Cells (IMS32)

Cat.No.: CSC-I9219L

Species: Mus musculus

Source: Brain

Morphology: Spindle-shaped

Culture Properties: Adherent

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-I9219L
Description
Schwann cells are valuable tools for diabetic neuropathy pathogenesis involving glycation, reduced regenerative capability, oxidative stress, and other neurodegenerative diseases. The Immortalized Mouse Schwann Cells express glial cell markers (S100, GFAP, p75NTR); transcription factors involved in Schwann cell development and peripheral myelin formation (Krox20, Oct6, PAX3, and SOX10); and neurotrophic factors (NGF, BDNF, GDNF, and CNTF). In the presence of growth factors, such as PDGF-BB, aFGF, bFGF, or TGF-β1, these cells exhibit mitogenic reponses. The IMS32 cells may be used to study action mechanisms involved in peripheral nerve regeneration, and as an in vitro model to assess the pathogenesis of neurological diseases.
Species
Mus musculus
Source
Brain
Culture Properties
Adherent
Morphology
Spindle-shaped
Immortalization Method
Spontaneous Immortalization
Application
For Research Use Only
Storage
Directly and immediately transfer cells from dry ice to liquid nitrogen upon receiving and keep the cells in liquid nitrogen until cell culture needed for experiments.

Note: Never can cells be kept at -20 °C.
Shipping
Dry Ice.
Recommended Products
CIK-HT003 HT® Lenti-SV40T Immortalization Kit
Quality Control
Immunoreactivity to cell markers
BioSafety Level
II
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

IMS32, also known as Immortalized Mouse Schwann cells clone 32, is a spontaneously immortalized cell line established from peripheral nerves and dorsal root ganglia of adult ICR mice at 4-6 weeks of age. Unlike primary Schwann cells-which have a finite lifespan and undergo phenotypic drift with serial passaging-IMS32 arose spontaneously from long‑term primary cultures and displays high proliferative activity while retaining the defining biological features of mature Schwann cells.

IMS32 exhibits the characteristic spindle‑shaped morphology of Schwann cells and expresses canonical glial markers, including S100, glial fibrillary acidic protein (GFAP), and the p75 low‑affinity neurotrophin receptor, as well as a variety of neurotrophic factors. Conditioned medium from IMS32 cultures promotes neurite outgrowth in PC12 cells and primary mouse dorsal root ganglion neurons, providing functional evidence of their neurotrophic secretome.

The primary advantage of IMS32 is its status as one of the best‑characterized and most widely used immortalized Schwann cell models available. It overcomes the experimental bottlenecks associated with primary Schwann cell isolation, including low yield, donor‑to‑donor variability, and rapid senescence in culture. IMS32 cells retain metabolic responsiveness to hyperglycemic and hyperlipidemic conditions, making them particularly valuable for investigating diabetic peripheral neuropathy-including polyol pathway hyperactivity, protein glycation, oxidative stress, and neurotrophic deficits-as well as for exploring the mechanisms underlying peripheral nerve regeneration and the development of novel neurological therapeutics.

Imeglimin Improves Hyperglycemia and Hypoglycemia-Induced Cell Death and Mitochondrial Dysfunction in Immortalized Adult Mouse Schwann IMS32 Cells

Imeglimin, a novel oral antidiabetic drug, enhances glucose-stimulated insulin secretion, improves insulin sensitivity, and reduces mitochondrial reactive oxygen species (ROS) generation. Diabetic neuropathy is driven by oxidative stress caused by hyperglycemia, with mitochondrial ROS overproduction playing a central role. Hypoglycemia also contributes to oxidative stress. This study evaluates the effects of imeglimin on Schwann cells under high- and low-glucose conditions.

We used IMS32 cells, an immortalized mouse Schwann cell line, to investigate cell survival and mitochondrial function under normal, high-, and low-glucose conditions. Assessments included mitochondrial oxidative stress, cytochrome c release, mitochondrial membrane potential, oxygen consumption rate (OCR), Complex I activity, and ATP synthesis.

High- and low-glucose conditions caused cell death, elevated mitochondrial ROS, triggered cytochrome c release, disrupted mitochondrial membrane potential, and increased OCR and Complex I activity, while suppressing ATP synthesis. Imeglimin treatment mitigated cell death, reduced oxidative stress, restored mitochondrial membrane potential, normalized OCR and Complex I activity, and improved ATP synthesis under both glucose conditions.

Imeglimin prevents cytochrome c release induced by high and low glucose.

Fig. 1. Cytochrome c distribution in IMS32 cells treated with or without 100 μM imeglimin under high- and low-glucose conditions (Kato, Ayako, et al., 2025).

Imeglimin reduces mitochondrial oxidative stress caused by high and low glucose levels.

Fig. 2. Mitochondrial oxidative stress in IMS32 cells treated with or without 100 μM imeglimin under high-and low-glucose conditions (Kato, Ayako, et al., 2025).

Ask a Question

Write your own review

For research use only. Not for any other purpose.

Hot Products